Elevance Health Inc (ELV) Stock Forecast & Price Target
Elevance Health Inc · NYSE
$385.67+7.31 (+1.93%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 20 firms covering Elevance Health Inc, 14 rate it Buy or better, 6 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $343.00 to $498.00, a moderate spread. The average target of $437.55 sits 13% above the current $385.67. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 13 to 14 over recent months. On the fundamentals, the Street sees consensus EPS building from about $2.47 next quarter toward $29.63 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS20 ratings
Moderate Buy
Strong Buy00%
Buy1470%
Hold630%
Sell00%
Strong Sell00%
Based on 20 analysts giving stock ratings to Elevance Health Inc.
As of Jul, 14 of 20 firms rate ELV a Buy (6 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
ELV EPS & revenue forecast
EPS · NEXT QUARTER
$2.47
Range $1.91 – $3.31 · 20 analysts · -26% YoY
Next period, 20 analysts expect Elevance Health Inc to earn $2.47 a share (range $1.91 – $3.31), versus $3.33 a year earlier. Full-year consensus is $27.16, growing to $29.63 the year after.
REVENUE · NEXT QUARTER
$48.1B
Range $46.6B – $49.7B · 20 analysts · -2% YoY
Revenue is expected to reach $48.1B (range $46.6B – $49.7B), -2.4% year-over-year. Full-year consensus is $196.2B, rising to $200.4B next year.
Top analysts covering Elevance Health Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ELV.
#1
DM
David Macdonald
Truist Securities · Rank #67
Buy
$475.00+23.2% to target
Overall win rate
51%
+ Follow
#2
Ben Hendrix
RBC Capital · Rank #117
Hold
$424.00+9.9% to target
Overall win rate
44%
+ Follow
#3
Stephen Baxter
Wells Fargo
Buy
$473.00+22.6% to target
Coverage
—
+ Follow
#4
Jason Cassorla
Guggenheim
Buy
$455.00+18.0% to target
Coverage
—
+ Follow
#5
Kevin Fischbeck
B of A Securities
Buy
$460.00+19.3% to target
Coverage
—
+ Follow
ELV stock forecast FAQ
What is ELV's average 12-month price target?+
The 20 analysts with a live target average $437.55 for Elevance Health Inc over the next 12 months, ranging from a $498.00 high to a $343.00 low.
Is ELV stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 20 analyst ratings, 14 are Buy or Strong Buy, 6 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for ELV?+
The Street-high target is $498.00 (Deutsche Bank), and the Street-low is $343.00 (Goldman Sachs). The average of all 20 active targets is $437.55.
How many Wall Street analysts cover ELV?+
20 analysts have an active rating on Elevance Health Inc, and 20 firms carry a live 12-month price target.
Who is the most accurate analyst covering ELV?+
Among analysts who currently cover ELV, David Macdonald of Truist Securities has the strongest overall Quantellect track record (Rank #67). Their current call is Buy with a $475.00 target.
What is Elevance Health Inc's projected EPS for next quarter?+
The consensus estimate is $2.47 per share (range $1.91 – $3.31) across 20 analysts. Full-year EPS is projected at $27.16, rising to $29.63 the following year.
How much revenue is Elevance Health Inc expected to report next quarter?+
Consensus revenue is $48.1B (range $46.6B – $49.7B). Full-year revenue is projected at $196.2B, growing to $200.4B next year.
Have analysts been upgrading or downgrading ELV lately?+
As of Jul, 14 of 20 firms rate ELV a Buy (6 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ELV calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
